Riverdale, NY, United States of America

Paul Gottlieb


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Riverdale, NY (US) (1999)
  • New York, NY (US) (1999)

Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Gottlieb: Innovator in Blood Parasite Inactivation

Introduction

Paul Gottlieb is a notable inventor based in Riverdale, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of blood safety. With a total of 2 patents to his name, his work focuses on innovative methods to enhance the safety of blood cell-containing compositions.

Latest Patents

Gottlieb's latest patents include groundbreaking methods for the use of phthalocyanines to inactivate blood-borne parasites. This invention relates to a method for inactivating parasites in blood cell-containing compositions by incubating a mixture of the blood cell-containing composition, a phthalocyanine dye, and a quencher. The process may also involve irradiating this mixture with red light. Furthermore, this invention addresses the sterilization of blood cell-containing compositions that contain lipid-enveloped viruses and blood-borne parasites.

Career Highlights

Paul Gottlieb is associated with the New York Blood Center, Inc., where he applies his expertise to improve blood safety and efficacy. His work has been instrumental in developing methods that could potentially save lives by ensuring the safety of blood transfusions.

Collaborations

Gottlieb has collaborated with esteemed colleagues such as Ehud Ben-Hur and Sara Lustigman. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

In summary, Paul Gottlieb is a distinguished inventor whose work in blood safety through innovative methods of inactivation of parasites has made a significant impact in the medical field. His contributions continue to pave the way for safer blood transfusions and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…